Accenture 2025 1H VEIP Review
The information below is informational only and isn’t advice for your specific scenario. You should work with your professional advisors when making decisions. Additionally, content is pulled from public sources, and Adventure Wealth has no affiliation with Accenture.
Accenture’s stock price has continued to take a beating since it peaked at $398.35 in February of this year.
Today’s current low of $258.24 is 35% lower than the February high and revisits lows that have happened only two times since the record high of $417 in January of 2022.
The previous lows of around $250 happened in October 2022 and March 2023. The difference between then and now is that the overall stock market is currently hitting record highs, while Accenture is dragging the bottom.
Previous lows coordinated more closely with stock market bottoms. While the S&P 500 is up 83% in the last five years, ACN is up a sad 9.24%
Accenture 2025 1H VEIP Review
Let’s examine the first half of the 2025 VEIP program year to see how the monthly purchases have performed.
The February purchases nearly coincided with the 2025 peak price, so it’s currently down 35% from the purchase. The average purchase for the first six purchases is $326.70, with the current price down 21%.
There’s no denying that this is a very troubling time to see what’s happened to your Accenture stock wealth, and even the 50% RSU grant you’ll receive on January 5, 2026 can’t make up for the current drop in value.
However, it’s also important to keep the broader strategy in mind. Let’s look at a couple of upsides.
VEIP RSU 50% match is based on number of shares purchased
When you complete your VEIP program year, your 50% VEIP RSU match is calculated based on the number of shares you purchased throughout the year.
If you max the VEIP at 30% and make $400,000 annually, you purchase $10,000 of shares each month. In February, you purchased 25 shares. If today’s stock price holds until August 5’s next purchase, you’ll purchase 38 shares! The difference in these two purchases would add ~6.5 RSU matching shares in August or almost $2,000 of value at $300/share.
Volatility is nothing new for Accenture’s stock price
While past performance is certainly no indicator of future performance, this isn’t the first time Accenture’s stock price sang the summer blues.
In fact, in the last four years, ACN peaked on the February purchase and dropped through summer. In 2023 and 2024, the July purchase was one of the more painful (opportunistic) and the price increased in the following months.
However, in 2022, the stock price continued to decline after the July purchase, which we can nearly guarantee will happen in August 2025.
Accenture stock price versus earnings per share (EPS)
The price-to-earnings (P/E) ratio is a decent way to track stock prices against annual “Diluted earnings per share.” If you look on Google or Yahoo Finance, the P/E is calculated based on the estimated 2025 diluted EPS of $12.58 per share.
The graph below reviews the P/E ratio based on the previous fiscal year’s EPS, so it’s a little different, but still gives us context into what’s happening.
The average P/E ratio of the last ten years is right around 26. Today’s P/E ratio based on $258/share is 22.55. If we look at an average P/E ratio since 2010, the average is closer to 21.6
As the chart above shows, the P/E ratio has dropped below the ten-year average and is approaching the lows of the last five years.
This is no indicator of what can happen next, but it can be interpreted that the market doesn’t have high hopes for future growth or that the market is underpricing the current value based on future growth.
Based on all of this, it’s important to remember the broader context when looking at Accenture’s stock price and VEIP program. The price goes up and down and gives you better purchasing opportunities.
However, even more importantly, this is a reminder of how important it is to have a VEIP selling strategy. As I analyzed in a previous post, the most consistent returns for Accenture MDs have come through maxing the VEIP and opportunistically selling shares to reinvest.
